FAH is proud to announce that Modern Healthcare’s “100 Most Influential People In Healthcare” list of nominees contains 10 leaders from our membership, including FAH President & CEO Chip Kahn. Voting for the list began […]
FAH Comments on CY 2022 Medicare OPPS Proposed Rule
In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]
Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule